Annovis Bio to Present at Biomarkers for Alzheimer’s Disease Summit 2021
Presentation will highlight positive biomarker data that corroborates the positive efficacy data from two Phase 2 studies of ANVS401 Dr. Maccecchini to present virtually, Thursday, August 26, at 1:00 p.m. ET Berwyn, Pennsylvania–(Newsfile Corp. – more...
New Study Confirms Sientra’s AlloX2’s Unique Value in Managing Seroma and Infection Post Reconstruction Procedures
SANTA BARBARA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgery, today announced that a recent independent study out of more...
ANVS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Annovis Bio, Inc.
New York, New York–(Newsfile Corp. – August 25, 2021) – The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Annovis Bio, Inc. (NYSE: ANVS) (“Annovis more...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting Officer, will succeed Robert O. Hopkins as more...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 – ANVS
New York, New York–(Newsfile Corp. – August 24, 2021) – The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Annovis Bio, more...
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
ROCKAWAY, NJ, Aug. 24, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a reseller agreement with Red One Medical Devices, LLC. (Red One). The partnership will further expand more...
Alimera Sciences Announces National Pricing and Reimbursement Granted for ILUVIEN® for DME in Belgium
ATLANTA, Aug. 24, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, announces that Alimera Sciences Europe Limited, its Ireland-based more...
Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Tempol Significantly Inhibited Multiple Cytokines from COVID-19 Patient’s Cells
Tempol: A potential home treatment for COVID-19 ( https://covid19.nih.gov/news-and-stories/tempol-potential-home-treatment-covid-19 ). Trial to begin shortly. SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced a publication in the peer reviewed more...
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 24, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. (‘Annovis’ or ‘the Company’) more...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of San Juan Basin Royalty Trust – SJT
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of San Juan Basin Royalty Trust – SJT PR Newswire NEW YORK , Aug. 23, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on more...